Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excis (Q34983138)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excis |
scientific article |
Statements
1 reference
Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excis (English)
1 reference
Cheryl A London
1 reference
Phyllis B Malpas
1 reference
Stacey L Wood-Follis
1 reference
Joseph F Boucher
1 reference
Anthony W Rusk
1 reference
Mona P Rosenberg
1 reference
Carolyn J Henry
1 reference
Kathy L Mitchener
1 reference
Mary K Klein
1 reference
John G Hintermeister
1 reference
Philip J Bergman
1 reference
Guillermo C Couto
1 reference
Guy N Mauldin
1 reference
Gina M Michels
1 reference
26 May 2009
1 reference
1 reference
15
1 reference
11
1 reference
3856-3865
1 reference
Identifiers
1 reference
1 reference